ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651851 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651851; 2) Community: the network communities that were significantly associated with the response to NSC 651851; 3) Molecule: the relationships between components within communities and NSC 651851; 4) MDR: the compounds that were significantly associated with the NSC 651851.

NSC Compound Enrichment Correlation
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.00433056621075589 0.4765088
NSC 249992 M-AMSA 0.00457614317494024 0.72872279
NSC 644945 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride 0.00457614317494024 0.78691807
NSC 660032 Null 0.00457614317494024 0.23033346
NSC 205862 Null 0.00479683626511385 0.31102987
NSC 609699 Topotecan hydrochloride 0.00479683626511385 0.53200981
NSC 610458 Camptothecin Derivative 0.00479683626511385 0.53716342
NSC 639186 Raltitrexed 0.00479683626511385 0.2754702
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00479683626511392 0.38078594
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00479683626511392 0.59324091
Total:52  Current:6    [First] [Prev] [Next] [Last]